Close Menu

NEW YORK – Noninvasive prenatal testing startup Cradle Genomics said today that it has raised $17.1 million in a Series A funding round.

The funding was led by Illumina Ventures and Section 32 with participation from Alexandria Real Estate Equities, Sea Lane Ventures, Listwin Ventures, and Axon Ventures.

The company, which is headquartered in San Diego and has R&D operations in Detroit, plans to use the proceeds to support clinical development, corporate infrastructure, CLIA lab operations, and the launch of products for NIPT.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.